Pulmonary embolism in patients with severe COVID-19 treated with systemic low-dose thrombolytic therapy: A case series

Coronavirus disease 2019 (COVID-19) has been associated with respiratory failure and high mortality. Hypercoagulability and thromboembolic complications have been found in a high percentage of patients amongst which, pulmonary embolism (PE) is the most common. Currently, there are no guidelines on u...

Descripción completa

Detalles Bibliográficos
Autores principales: Aribawa, I Gusti Ngurah Mahaalit, Ryalino, Christopher, Pradhana, Adinda Putra, Dewi, Putu Utami, Sinardja, Cyndiana Widia Dewi, Mulyantari, Ni Kadek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910114/
https://www.ncbi.nlm.nih.gov/pubmed/36779212
http://dx.doi.org/10.4103/ijciis.ijciis_53_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910114/
https://www.ncbi.nlm.nih.gov/pubmed/36779212
http://dx.doi.org/10.4103/ijciis.ijciis_53_22

Ejemplares similares